Table S1-S3 from Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti–PD-1 Antibody Article Swipe

View

Yuki Niwa , Keito Adachi , Kimiyo Tabata , Ryoga Ishida , Koichiro Hotta , Tomomi Ishida , Yuji Mano , Yoichi Ozawa , Yukinori Minoshima , Yasuhiro Funahashi , Taro Semba ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/1535-7163.22495287.v1

Antibody lists used in the flow cytometric analysis

Related Topics

Concepts

Eribulin Antibody Liposome Cancer research Chemistry Antibody therapy Pharmacology Medicine Monoclonal antibody Internal medicine Immunology Cancer Metastatic breast cancer Biochemistry Breast cancer

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/1535-7163.22495287.v1
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4362479969

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4362479969

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1535-7163.22495287.v1

Digital Object Identifier
Title: Table S1-S3 from Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti–PD-1 Antibody

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-04-03

Full publication date if available
Authors: Yuki Niwa, Keito Adachi, Kimiyo Tabata, Ryoga Ishida, Koichiro Hotta, Tomomi Ishida, Yuji Mano, Yoichi Ozawa, Yukinori Minoshima, Yasuhiro Funahashi, Taro Semba

List of authors in order
Landing page: https://doi.org/10.1158/1535-7163.22495287.v1

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/1535-7163.22495287.v1

Direct OA link when available
Concepts: Eribulin, Antibody, Liposome, Cancer research, Chemistry, Antibody therapy, Pharmacology, Medicine, Monoclonal antibody, Internal medicine, Immunology, Cancer, Metastatic breast cancer, Biochemistry, Breast cancer

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4362479969
doi	https://doi.org/10.1158/1535-7163.22495287.v1
ids.doi	https://doi.org/10.1158/1535-7163.22495287.v1
ids.openalex	https://openalex.org/W4362479969
fwci	0.0
type	preprint
title	Table S1-S3 from Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti–PD-1 Antibody
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T13128
topics[0].field.id	https://openalex.org/fields/16
topics[0].field.display_name	Chemistry
topics[0].score	0.9577999711036682
topics[0].domain.id	https://openalex.org/domains/3
topics[0].domain.display_name	Physical Sciences
topics[0].subfield.id	https://openalex.org/subfields/1602
topics[0].subfield.display_name	Analytical Chemistry
topics[0].display_name	Chromatography in Natural Products
topics[1].id	https://openalex.org/T11752
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9506999850273132
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2730
topics[1].subfield.display_name	Oncology
topics[1].display_name	Cancer Treatment and Pharmacology
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2776387010
concepts[0].level	5
concepts[0].score	0.980708122253418
concepts[0].wikidata	https://www.wikidata.org/wiki/Q408717
concepts[0].display_name	Eribulin
concepts[1].id	https://openalex.org/C159654299
concepts[1].level	2
concepts[1].score	0.6357720494270325
concepts[1].wikidata	https://www.wikidata.org/wiki/Q79460
concepts[1].display_name	Antibody
concepts[2].id	https://openalex.org/C185154212
concepts[2].level	2
concepts[2].score	0.5274218320846558
concepts[2].wikidata	https://www.wikidata.org/wiki/Q410454
concepts[2].display_name	Liposome
concepts[3].id	https://openalex.org/C502942594
concepts[3].level	1
concepts[3].score	0.48160669207572937
concepts[3].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[3].display_name	Cancer research
concepts[4].id	https://openalex.org/C185592680
concepts[4].level	0
concepts[4].score	0.4405995011329651
concepts[4].wikidata	https://www.wikidata.org/wiki/Q2329
concepts[4].display_name	Chemistry
concepts[5].id	https://openalex.org/C2908856526
concepts[5].level	4
concepts[5].score	0.4179079532623291
concepts[5].wikidata	https://www.wikidata.org/wiki/Q16252627
concepts[5].display_name	Antibody therapy
concepts[6].id	https://openalex.org/C98274493
concepts[6].level	1
concepts[6].score	0.41203704476356506
concepts[6].wikidata	https://www.wikidata.org/wiki/Q128406
concepts[6].display_name	Pharmacology
concepts[7].id	https://openalex.org/C71924100
concepts[7].level	0
concepts[7].score	0.3904590606689453
concepts[7].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[7].display_name	Medicine
concepts[8].id	https://openalex.org/C542903549
concepts[8].level	3
concepts[8].score	0.26891347765922546
concepts[8].wikidata	https://www.wikidata.org/wiki/Q422248
concepts[8].display_name	Monoclonal antibody
concepts[9].id	https://openalex.org/C126322002
concepts[9].level	1
concepts[9].score	0.2687762379646301
concepts[9].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[9].display_name	Internal medicine
concepts[10].id	https://openalex.org/C203014093
concepts[10].level	1
concepts[10].score	0.20175299048423767
concepts[10].wikidata	https://www.wikidata.org/wiki/Q101929
concepts[10].display_name	Immunology
concepts[11].id	https://openalex.org/C121608353
concepts[11].level	2
concepts[11].score	0.1741039752960205
concepts[11].wikidata	https://www.wikidata.org/wiki/Q12078
concepts[11].display_name	Cancer
concepts[12].id	https://openalex.org/C2775930923
concepts[12].level	4
concepts[12].score	0.12494978308677673
concepts[12].wikidata	https://www.wikidata.org/wiki/Q12859063
concepts[12].display_name	Metastatic breast cancer
concepts[13].id	https://openalex.org/C55493867
concepts[13].level	1
concepts[13].score	0.09789127111434937
concepts[13].wikidata	https://www.wikidata.org/wiki/Q7094
concepts[13].display_name	Biochemistry
concepts[14].id	https://openalex.org/C530470458
concepts[14].level	3
concepts[14].score	0.08069244027137756
concepts[14].wikidata	https://www.wikidata.org/wiki/Q128581
concepts[14].display_name	Breast cancer
keywords[0].id	https://openalex.org/keywords/eribulin
keywords[0].score	0.980708122253418
keywords[0].display_name	Eribulin
keywords[1].id	https://openalex.org/keywords/antibody
keywords[1].score	0.6357720494270325
keywords[1].display_name	Antibody
keywords[2].id	https://openalex.org/keywords/liposome
keywords[2].score	0.5274218320846558
keywords[2].display_name	Liposome
keywords[3].id	https://openalex.org/keywords/cancer-research
keywords[3].score	0.48160669207572937
keywords[3].display_name	Cancer research
keywords[4].id	https://openalex.org/keywords/chemistry
keywords[4].score	0.4405995011329651
keywords[4].display_name	Chemistry
keywords[5].id	https://openalex.org/keywords/antibody-therapy
keywords[5].score	0.4179079532623291
keywords[5].display_name	Antibody therapy
keywords[6].id	https://openalex.org/keywords/pharmacology
keywords[6].score	0.41203704476356506
keywords[6].display_name	Pharmacology
keywords[7].id	https://openalex.org/keywords/medicine
keywords[7].score	0.3904590606689453
keywords[7].display_name	Medicine
keywords[8].id	https://openalex.org/keywords/monoclonal-antibody
keywords[8].score	0.26891347765922546
keywords[8].display_name	Monoclonal antibody
keywords[9].id	https://openalex.org/keywords/internal-medicine
keywords[9].score	0.2687762379646301
keywords[9].display_name	Internal medicine
keywords[10].id	https://openalex.org/keywords/immunology
keywords[10].score	0.20175299048423767
keywords[10].display_name	Immunology
keywords[11].id	https://openalex.org/keywords/cancer
keywords[11].score	0.1741039752960205
keywords[11].display_name	Cancer
keywords[12].id	https://openalex.org/keywords/metastatic-breast-cancer
keywords[12].score	0.12494978308677673
keywords[12].display_name	Metastatic breast cancer
keywords[13].id	https://openalex.org/keywords/biochemistry
keywords[13].score	0.09789127111434937
keywords[13].display_name	Biochemistry
keywords[14].id	https://openalex.org/keywords/breast-cancer
keywords[14].score	0.08069244027137756
keywords[14].display_name	Breast cancer
language	en
locations[0].id	doi:10.1158/1535-7163.22495287.v1
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1535-7163.22495287.v1
locations[1].id	pmh:oai:figshare.com:article/22495287
locations[1].is_oa	True
locations[1].source.id	https://openalex.org/S4306400572
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	OPAL (Open@LaTrobe) (La Trobe University)
locations[1].source.host_organization	https://openalex.org/I196829312
locations[1].source.host_organization_name	La Trobe University
locations[1].source.host_organization_lineage	https://openalex.org/I196829312
locations[1].license	cc-by
locations[1].pdf_url
locations[1].version	submittedVersion
locations[1].raw_type	Text
locations[1].license_id	https://openalex.org/licenses/cc-by
locations[1].is_accepted	False
locations[1].is_published	False
locations[1].raw_source_name
locations[1].landing_page_url	https://figshare.com/articles/journal_contribution/Table_S1-S3_from_Liposome-Encapsulated_Eribulin_Shows_Enhanced_Antitumor_Activity_over_Eribulin_for_Combination_Therapy_with_Anti_PD-1_Antibody/22495287
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5033578823
authorships[0].author.orcid	https://orcid.org/0000-0001-8991-0155
authorships[0].author.display_name	Yuki Niwa
authorships[0].author_position	first
authorships[0].raw_author_name	Yuki Niwa
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5006331651
authorships[1].author.orcid	https://orcid.org/0000-0002-8228-032X
authorships[1].author.display_name	Keito Adachi
authorships[1].author_position	middle
authorships[1].raw_author_name	Keito Adachi
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5028733380
authorships[2].author.orcid	https://orcid.org/0000-0001-5116-4740
authorships[2].author.display_name	Kimiyo Tabata
authorships[2].author_position	middle
authorships[2].raw_author_name	Kimiyo Tabata
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5038712808
authorships[3].author.orcid	https://orcid.org/0000-0001-7071-7777
authorships[3].author.display_name	Ryoga Ishida
authorships[3].author_position	middle
authorships[3].raw_author_name	Ryoga Ishida
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5002661842
authorships[4].author.orcid	https://orcid.org/0000-0002-9787-3945
authorships[4].author.display_name	Koichiro Hotta
authorships[4].author_position	middle
authorships[4].raw_author_name	Koichiro Hotta
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5067587493
authorships[5].author.orcid	https://orcid.org/0000-0003-3278-3743
authorships[5].author.display_name	Tomomi Ishida
authorships[5].author_position	middle
authorships[5].raw_author_name	Tomomi Ishida
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5045436087
authorships[6].author.orcid	https://orcid.org/0000-0002-8537-951X
authorships[6].author.display_name	Yuji Mano
authorships[6].author_position	middle
authorships[6].raw_author_name	Yuji Mano
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5008447763
authorships[7].author.orcid	https://orcid.org/0000-0002-3753-3703
authorships[7].author.display_name	Yoichi Ozawa
authorships[7].author_position	middle
authorships[7].raw_author_name	Yoichi Ozawa
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5019354683
authorships[8].author.orcid	https://orcid.org/0000-0002-6351-6624
authorships[8].author.display_name	Yukinori Minoshima
authorships[8].author_position	middle
authorships[8].raw_author_name	Yukinori Minoshima
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5003415756
authorships[9].author.orcid	https://orcid.org/0000-0002-9299-0704
authorships[9].author.display_name	Yasuhiro Funahashi
authorships[9].author_position	middle
authorships[9].raw_author_name	Yasuhiro Funahashi
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5015177508
authorships[10].author.orcid	https://orcid.org/0000-0003-0432-1138
authorships[10].author.display_name	Taro Semba
authorships[10].author_position	last
authorships[10].raw_author_name	Taro Semba
authorships[10].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/1535-7163.22495287.v1
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Table S1-S3 from Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti–PD-1 Antibody
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T13128
primary_topic.field.id	https://openalex.org/fields/16
primary_topic.field.display_name	Chemistry
primary_topic.score	0.9577999711036682
primary_topic.domain.id	https://openalex.org/domains/3
primary_topic.domain.display_name	Physical Sciences
primary_topic.subfield.id	https://openalex.org/subfields/1602
primary_topic.subfield.display_name	Analytical Chemistry
primary_topic.display_name	Chromatography in Natural Products
related_works	https://openalex.org/W2965620940, https://openalex.org/W2117905001, https://openalex.org/W2612536017, https://openalex.org/W2316739971, https://openalex.org/W2994912919, https://openalex.org/W2809136906, https://openalex.org/W3007495492, https://openalex.org/W2945189018, https://openalex.org/W2613079882, https://openalex.org/W2021084977
cited_by_count	0
locations_count	2
best_oa_location.id	doi:10.1158/1535-7163.22495287.v1
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1535-7163.22495287.v1
primary_location.id	doi:10.1158/1535-7163.22495287.v1
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1535-7163.22495287.v1
publication_date	2023-04-03
publication_year	2023
referenced_works_count	0
abstract_inverted_index.in	3
abstract_inverted_index.the	4
abstract_inverted_index.flow	5
abstract_inverted_index.used	2
abstract_inverted_index.lists	1
abstract_inverted_index.cytometric	6
abstract_inverted_index.<p>Antibody	0
abstract_inverted_index.analysis</p>	7
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	11
citation_normalized_percentile.value	0.04718299
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False